KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Assets: 2011-2025

Historic Return on Assets for Rigel Pharmaceuticals (RIGL) over the last 13 years, with Sep 2025 value amounting to 0.50%.

  • Rigel Pharmaceuticals' Return on Assets rose 48.00% to 0.50% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.50%, marking a year-over-year increase of 48.00%. This contributed to the annual value of 0.12% for FY2024, which is 32.00% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Return on Assets of 0.50% as of Q3 2025, which was down 1.33% from 0.51% recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Return on Assets peaked at 0.51% during Q2 2025, and registered a low of -0.68% during Q3 2022.
  • Its 3-year average for Return on Assets is 0.00%, with a median of -0.11% in 2024.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Return on Assets crashed by 60bps in 2022, and later skyrocketed by 62bps in 2025.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Return on Assets stood at -0.10% in 2021, then crashed by 37bps to -0.47% in 2022, then grew by 25bps to -0.22% in 2023, then surged by 33bps to 0.12% in 2024, then soared by 48bps to 0.50% in 2025.
  • Its Return on Assets was 0.50% in Q3 2025, compared to 0.51% in Q2 2025 and 0.22% in Q1 2025.